<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00455793</url>
  </required_header>
  <id_info>
    <org_study_id>2006-P-000238</org_study_id>
    <nct_id>NCT00455793</nct_id>
  </id_info>
  <brief_title>Subclinical Atherosclerosis in HIV-infected Patients</brief_title>
  <official_title>Subclinical Atherosclerosis in HIV-infected Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will obtain data using multi-slice CT technology to detect subclinical coronary disease in&#xD;
      the HIV population. Determination of subclinical cardiovascular disease using noninvasive&#xD;
      technology and elucidation of the associated risk factors will help to guide targeted therapy&#xD;
      to prevent cardiovascular events in this patient population.&#xD;
&#xD;
      We will investigate the prevalence of coronary plaque lesions and coronary artery&#xD;
      calcifications in men and women with HIV disease as determined by 64-row multidetector&#xD;
      computed tomography (MDCT) and MDCT coronary angiography in comparison to age-matched control&#xD;
      subjects without HIV infection. We hypothesize that evidence of coronary artery calcification&#xD;
      and coronary plaque lesions as seen by MDCT will be present in individuals with HIV more than&#xD;
      non-HIV control subjects of the same age. We also hypothesize the degree of atherosclerosis&#xD;
      will be increased in HIV patients compared to control subjects.&#xD;
&#xD;
      We will evaluate the metabolic and inflammatory factors associated with coronary artery&#xD;
      disease in HIV-infected individuals. We hypothesize that traditional cardiac risk factors as&#xD;
      well as metabolic and inflammatory changes associated with HIV and its treatment such as&#xD;
      dyslipidemia, increased secretion of inflammatory markers, decreased adiponectin, increased&#xD;
      insulin resistance and increased visceral fat may be associated with coronary artery disease&#xD;
      in HIV-infected individuals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary Plaque</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory indices, glucose homeostasis, body composition</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">263</enrollment>
  <condition>HIV Infections</condition>
  <condition>Coronary Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Non-HIV infected controls</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV infected men and women and non-HIV infected control men and women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for HIV infected subjects arm:&#xD;
&#xD;
          1. Men and women age 18-60&#xD;
&#xD;
          2. BMI 20-35&#xD;
&#xD;
          3. Previously documented HIV disease for 5 years or longer either on stable highly active&#xD;
             anti-retroviral therapy (HAART) or not on HAART.&#xD;
&#xD;
          4. No changes in antiretroviral regimen within the prior 3 months.&#xD;
&#xD;
        Inclusion criteria for non-HIV infected control subjects arm:&#xD;
&#xD;
          1. Healthy men and women age 18-60&#xD;
&#xD;
          2. BMI 20-35&#xD;
&#xD;
        Exclusion criteria for both arms:&#xD;
&#xD;
          1. Previously diagnosed coronary artery disease, cerebrovascular disease, or peripheral&#xD;
             vascular disease.&#xD;
&#xD;
          2. Use of glucocorticoids, growth hormone, testosterone, or other anabolic agents within&#xD;
             past 6 months&#xD;
&#xD;
          3. Renal disease or creatinine &gt;1.5 mg/dL&#xD;
&#xD;
          4. Anti-inflammatory medications&#xD;
&#xD;
          5. Opportunistic infection within past 6 months in HIV infected individuals and current&#xD;
             acute infectious illness in both HIV-infected subjects and normal controls.&#xD;
&#xD;
          6. Nitrates or others medications that can alter endothelial function&#xD;
&#xD;
          7. Contraindication to beta-blocker use&#xD;
&#xD;
          8. Body weight greater than 300 lbs due to DEXA scanner table limitations&#xD;
&#xD;
          9. Patients with previous allergic reactions to iodine-containing contrast media or to&#xD;
             iodine will be excluded from participation&#xD;
&#xD;
         10. Active illicit drug use&#xD;
&#xD;
         11. Pregnancy or breastfeeding&#xD;
&#xD;
         12. Estrogen or progestin use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Grinspoon</last_name>
    <role>Principal Investigator</role>
    <affiliation>MGH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>April 2, 2007</study_first_submitted>
  <study_first_submitted_qc>April 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2007</study_first_posted>
  <last_update_submitted>November 27, 2013</last_update_submitted>
  <last_update_submitted_qc>November 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Steven K. Grinspoon, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

